Peptide selection by MHC class I molecules
Ton N. Schumacher(Leiden University Medical Center), Hidde L. Ploegh(Boston Children's Hospital), Jacques Neefjes(Leiden University Medical Center), W. Martin Kast(University of Southern California), Leen N. Vernie(The Netherlands Cancer Institute), Cornelis J.M. Melief(Leiden University), Marloes L. H. De Bruijn(National Institutes of Health)
Cited by 252
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840